4.5 Article

Locus-Specific Databases and Recommendations to Strengthen Their Contribution to the Classification of Variants in Cancer Susceptibility Genes

期刊

HUMAN MUTATION
卷 29, 期 11, 页码 1273-1281

出版社

WILEY
DOI: 10.1002/humu.20889

关键词

locus-specific databases; LSDBs; BIC; mismatch repair; cancer; unclassified variant; variant of unknown significance; pathogenic

资金

  1. National Institutes Of Health [CA 96536, HG 004064]
  2. Lake Champlain Cancer Research Organization
  3. National Human Genomic Research Institute
  4. Fonds de la Recherche en Sante du Quebec
  5. Canadian Breast Cancer Research Alliance
  6. Elite Cassa di Risparmio di Firenze
  7. Dutch Cancer Society [RUG2002-2678]
  8. European Community
  9. Australian National Health and Medical Research Council

向作者/读者索取更多资源

Locus-specific databases (LSDBs) are curated collections of sequence variants in genes associated with disease. LSDBs of cancer-related genes often serve as a critical resource to researchers, diagnostic laboratories, clinicians, and others in the cancer genetics community. LSDBs are poised to play an important role in disseminating clinical classification of variants. The IARC Working Group on Unclassified Genetic Variants has proposed a new system of five classes of variants in cancer susceptibility genes. However, standards are lacking for reporting and analyzing the multiple data types that assist in classifying variants. By adhering to standards of transparency and consistency in the curation and annotation of data, LSDBs can be critical for organizing our understanding of how genetic variation relates to disease. In this article we discuss how LSDBs can accomplish these goals, using existing databases for BRCA1, BRCA2, MSH2, MLH1, TP53, and CDKN2A to illustrate the progress and remaining challenges in this field. We recommend that: 1) LSDBs should only report a conclusion related to pathogenicity if a consensus has been reached by an expert panel. 2) The system used to classify variants should be standardized. The Working Group encourages use of the five class system described in this issue by Plon and colleagues. 3) Evidence that supports a conclusion should be reported in the database, including sources and criteria used for assignment. 4) Variants should only be classified as pathogenic if more than one type of evidence has been considered. 5) All instances of all variants should be recorded. Hum Mutat 29(11), 1273-1281, 2008. Published 2008 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据